Tag: Coronavirus information (COVID-19)
Drug Research
Memo Therapeutics and Northway Biotech collaborate on the fast-track manufacturing of a SARS-CoV-2-neutralizing antibody for the therapy of COVID-19
Swiss biotech company Memo Therapeutics AG (MTx), and Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announce a new partnership...
News
COVID-19: Potential Vaccines and Logistics
While pharmaceuticals contribute to approximately 2% of annual air cargo volume, the industry transports over one trillion dollars’ worth of cargo every year (IATA)....
News
China grants country’s first Covid-19 vaccine patent to CanSino
China's vaccine maker CanSino Biologics Inc has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, People's Daily reported, citing documents...
News
Russia’s COVID-19 vaccine to enter production, deliver first batch of doses in two weeks
The world's first vaccine registered by Russian authorities, and now the World Health Organisation has said it is in talks with Russia's health ministry...
News
TIACA and Pharma.Aero Join Forces to Prepare Air Cargo Industry for COVID-19 Vaccine
The International Air Cargo Association (TIACA) and Pharma.Aero have joined forces to develop global guidance for the air cargo industry to enable optimal transportation...
Drug Research
Caprion-HistoGeneX, Viroclinics-DDL Announce COVID-19 Research Partnership
Caprion-HistoGeneX and Viroclinics-DDL announced a new strategic partnership to expand their global capabilities addressing the emerging needs for therapeutic and prophylactic solutions to target...
News
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
Pfizer Inc. and BioNTech SE announced that preliminary, peer-reviewed data from their BNT162 mRNA-based vaccine development program, Project Lightspeed, against SARS-CoV-2, were published online...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read